Tamtam Try Tamtam free
Temple Health – Temple University Health System logo

Temple Health – Temple University Health System account plan

Advanced medical research and care

At a glance

Temple Health is a Philadelphia nonprofit academic health system with $3,294,194K of FY2025 revenue, Temple University Hospital and Fox Chase Cancer Center.

Temple University Health System (Temple Health) is a Pennsylvania nonprofit whose sole member is Temple University. It coordinates hospitals, physician groups and a cancer center in Philadelphia and the surrounding area, including Temple University Hospital, the teaching hospital of the Lewis Katz School of Medicine, and Fox Chase Cancer Center. It serves a disproportionately high number of poor or indigent patients, relying heavily on Medicare, Medicaid and Commonwealth of Pennsylvania support. In FY2025 (year to June 30, 2025) revenues and other support were $3,294,194K and operating income $21,948K. Abhi Rastogi succeeded Michael Young as President and CEO on Jan. 2; the documents give no headcount.

Business units

Strategic priorities

Workforce stability
New CEO Abhi Rastogi names stabilising the physician workforce and staff as a first priority.
Footprint and access expansion
Expand Temple's footprint to make it a convenient option for more patients, building on Temple Women & Families Hospital, opened in September 2025, and the Episcopal Campus Crisis Response Center.
Clinical service lines
Grow transplant (led by lung, liver and kidney), cardiology, cancer care at Fox Chase, neurology and urology.
Revenue cycle and EPIC optimisation
Optimise EPIC revenue-cycle technology to reach nine EPIC stars; collections are up $15.0M-$20.0M per month after the fiscal 2024 EPIC implementation.
AI, technology and automation
Use AI and technology where appropriate, including automating scheduling to save labour and improve patient satisfaction and access.
Balance sheet and system integration
The investor presentation's vision: operational performance while strengthening the balance sheet, balanced capital investment, and system integration with the patient always first.

Latest results

In FY2025 (year to June 30, 2025) revenues and other support rose to $3,294,194K from $2,859,358K, and operating income rose to $21,948K from $973K. Net patient service revenue excluding Commonwealth funding grew $308,177,000, mostly outpatient, "largely driven by performance of the specialty and retail pharmacies", while operating expenses rose $413,861,000, led by supplies and pharmaceuticals and insurance. Net income was $92,141,000 after a $41,992,000 pension settlement charge. Days cash on hand fell to 116 from 124. The statements give no guidance.

Investments and deals

Capital spending
Purchases of property, plant and equipment were $103,133K in FY2025 (FY2024: $76,516K); capitalised internal-use software totals $88,062K.
New facilities
Temple Women & Families Hospital, an Intermediate Care Unit at TUH-Main and the Episcopal Campus Crisis Response Center all opened in September 2025.
Chestnut Hill Hospital stake
Bought Redeemer Health's 20% interest on August 28, 2025 for a $6,211,000 promissory note at 5% due September 1, 2027, on top of its existing 60% stake.
Pension settlement
Settled the defined benefit plan in FY2025 with $81,729,000 of annuity purchases, triggering a $41,992,000 charge.

Challenges and risks

Medicaid cuts and public funding
More than 40% of patients admitted to Temple University Hospital are on Medicaid, as hospitals prepare for major Medicaid cuts; Commonwealth support of $564,048K is not guaranteed to continue.
Drug and supply costs
Supplies and pharmaceuticals rose to $836,852K from $672,000K on outpatient infusion and pharmacy volumes; Jefferson Health Plan losses of $15.2M came largely from GLP-1 costs.
Professional liability
Insurance expense rose to $124,861K from $80,515K as old professional liability cases were settled; the discounted liability was $273,592K.
Thin operating margin
Operating income of $21,948K on $3,294,194K of revenue, with operating cash flow falling to $35,917K from $98,886K.

What leadership says

“Mike has left us in a position of strategic growth and financial stability. We want to continue that”

Abhi Rastogi, President and CEO · The Philadelphia Inquirer, 30 October 2025

“Not all of our patient populations could adapt to it, but where it's applicable, we need to make it easier for them to get access to the care”

Abhi Rastogi, President and CEO · The Philadelphia Inquirer, 30 October 2025, on AI and technology

Where a supplier can help

Patient access and scheduling automation
Tied to the AI and automation priority: automated scheduling to save labour and improve access is an explicit initiative.
Revenue-cycle optimisation on EPIC
Tied to the revenue cycle priority: the goal of nine EPIC stars and dependence on Medicare and Medicaid audits favour billing, denials and collections tools.
Pharmacy and drug-cost management
Tied to the drug and supply cost challenge: rising pharmaceutical spend, GLP-1 costs and the 340B programme make pharmacy analytics relevant.
Workforce and staffing solutions
Tied to the workforce stability priority and higher nursing pay rates: retention, scheduling and staffing tools fit the new CEO's agenda.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Temple Health – Temple University Health System?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Temple Health – Temple University Health System

What is Temple University Health System?

A Philadelphia nonprofit academic health system owned by Temple University, running Temple University Hospital, Fox Chase Cancer Center, physician groups and other subsidiaries.

What was Temple Health's revenue in FY2025?

Revenues and other support were $3,294,194K in the year to June 30, 2025, with operating income of $21,948K.

Who leads Temple Health?

Abhi Rastogi, at Temple for 23 years, succeeded Michael Young as President and CEO on Jan. 2; Jerry Oetzel is CFO.

What are Temple Health's priorities?

Workforce stability, expanding its footprint and access, growing transplant, cardiology, cancer, neurology and urology, optimising the EPIC revenue cycle, and using AI where appropriate.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)